CompletedNot Applicable

Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

Philippines508 participantsStarted 2011-02

Plain-language summary

This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over-active bladder * Prescribed with Fesoterodine Exclusion Criteria: * Hypersensitivity * Urinary retention

What they're measuring

Number of Participants With Adverse Events (AEs) by Seriousness, Severity and Relationship to Treatment

Timeframe: Baseline up to 28 days after last dose

Trial details

NCT IDNCT01260311

SponsorPfizer

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2013-10

Results submitted2014-09-04

View on ClinicalTrials.gov More Over Active Bladder trials